Preimplantation Genetic Testing Market Regional Analysis:
North American Market Insights
The market share of preimplantation genetic testing in North America, amongst the market in all the other regions, is projected to be the largest with a share of about 38% by the end of 2035. The growth of the market can be attributed majorly to the rising cases of infertility in the region. According to Statistics Canada, in 2023, Canada's fertility rate is expected to be around 1.484 births per woman, a nearly 0.54% decrease from 2022. In Canada, the fertility rate fell by around 0.53% from 2021 to 2022, to around 1.492 births per woman. On the other hand, market growth in the region is also expected on the account of the rising need for bone marrow transplantation and organ transplantation. In the United States in 2020, more than 23,000 bone marrow or umbilical cord blood transplants were carried out.
Europe Market Insights
The European preimplantation genetic testing market is estimated to be the second largest, registering a share of about 25% by the end of 2035. The growth of the market can be attributed majorly to the rising frequency of neo natal deaths. According to the Eurostat, in the EU, there were approximately 14 100 infant deaths in 2019. This translates to 3.4 newborn deaths for every 1000 live births, or the infant mortality rate. In addition to this, growing cases of congenital genetic deformity are also anticipated to boost the market growth in Europe. In the EU, there were approximately 14 100 infant deaths in 2019. This translates to 3.4 newborn deaths for every 1000 live births, or the infant mortality rate. Moreover, in Europe, the average age of first-time motherhood is also increasing which in turn pushing people to go for in-vitro fertilization in order to conceive.
APAC Market Insights
Asia Pacific region is projected to observe substantial growth through 2035. The growth of the market can be attributed majorly to the increasing instances of stem cells, organ, and bone marrow transplants. Any sort of transplantation has become safer with the use of preimplantation genetic testing, that ensures if the donor is healthy enough to donate and if receiver is getting the donation from its perfect match. Around 2,000 stem cell transplants are performed in India each year, 80,000 to 1,00,000 transplants are needed each year to address the high incidence of blood malignancies and severe blood diseases. However, finding a compatible donor is quite challenging. Moreover, less than a million Indian bone marrow donors are listed on the registry.
